No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use*
-
Body Weight
-
C-Reactive Protein / analysis
-
COVID-19 / blood*
-
COVID-19 / complications
-
Dose-Response Relationship, Drug
-
Enoxaparin / administration & dosage
-
Enoxaparin / therapeutic use*
-
Female
-
Fibrin Fibrinogen Degradation Products / analysis*
-
Guideline Adherence
-
Humans
-
Incidence
-
Intensive Care Units / statistics & numerical data
-
Kidney / physiopathology*
-
Male
-
Mean Platelet Volume
-
Middle Aged
-
Oxygen / blood
-
Practice Guidelines as Topic
-
Proportional Hazards Models
-
Retrospective Studies
-
Risk Factors
-
SARS-CoV-2*
-
Thrombophilia / drug therapy*
-
Thrombophilia / etiology
-
Thrombosis / epidemiology
-
Thrombosis / etiology
-
Thrombosis / prevention & control*
Substances
-
Anticoagulants
-
Enoxaparin
-
Fibrin Fibrinogen Degradation Products
-
fibrin fragment D
-
C-Reactive Protein
-
Oxygen